The Effect of Leaf, Fruit and Root Extract of Noni Plant (Morinda citrifolia) on Triple Negative Breast Cancer Cell Growth
ISEF · 2025 Translational Medical Science
Overview
Cancer is currently the second leading cause of death in the world. There are several treatments available, but most have side effects or are highly expensive. Therefore, it is necessary to explore new natural alternatives to treat it. This research aims to determine whether the Noni plant can inhibit the growth of cancer cells. The Noni plant (Morinda citrifolia) has been shown to possess various properties, including antioxidant, anti-inflammatory, and anticancer effects, among others. In this study, triple negative breast cancer cells (MDA-MB-231) were used, as it is the most aggressive form of breast cancer. Three extracts (fruit, root, and leaf) from the Noni plant were prepared. The TNBC cells were then cultured in RPMI and exposed to the extracts for 24, 48, and 72 hours, in serial dilutions. The results indicated that all extracts inhibited the growth of cancer cells. However, the leaf extract was the most effective at 72 hours of exposure, and an ANOVA test confirmed a significant difference when comparing cells without the extract to those treated with the leaf extract and the pure compound (damnacantal).
Competition history
- ISEF 2025
Resources
Related projects
ISEF · 2025
Investigation of a Safer Treatment for Lung Cancer Using a Traditional Hawaiian Herb, Morinda citrifolia (Noni)
ISEF · 2026
Investigation of the Molecular Mechanism Underlying the Anticancer Activity of the Native Hawaiian Herb Morinda citrifolia: A Safer Alternative for Treating Lung Cancer
ISEF · 2022
Investigating the Cytotoxicity of Centella asiatica Methanolic Leaf Extracts on MDA-MB-231 Human Breast Cancer Cells
ISEF · 2017
The Cytotoxicity Effect of Nephelium lappaceum Leaf Extract on Human Cancer Cells
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair